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ABSTRACT
Background and the Purpose of the study: Central Angiotensin Converting Enzyme (ACE) has 
an important role on cerebral microcirculation and metabolism. However, its role in terms of 
protecting the brain from ischemic/reperfusion (I/R) injury are debatable. This study evaluated 
the role of ACE, using enalapril as ACE inhibitor, in protection of the brain from I/R injury 
during transient focal cerebral ischemia (TFCI) in normotensive rat. 
Method: Male Sprague Dawley rats (280-320g) randomly assigned to control ischemic and 
enalapril pre-treated ischemic groups. Enalapril was injected intraperitoneally 1 h before middle 
cerebral artery occlusion (MCAO) at the dose of 0.03 or 0.1 mg/kg. Cerebral ischemia was 
induced by 60 min MCAO followed by 24 hrs reperfusion. After evaluation of neurological 
deficit  scores  (NDS)  the  animal  was  sacrificed  for  assessment  of  cerebral  infarction  and 
edema. 
Results: TFCI induced cerebral infarctions (283±18 mm3), brain edema (4.1±0.4%) and swelling 
(9.8±1.5%) with NDS of 3.11±0.36. Non-hypotensive dose of enalapril (0.03 mg/kg) improved NDS 
(1.37±0.26), reduced cerebral infarction (45%), brain edema (54%) and swelling of  the 
lesioned hemispheres (34%) significantly. However, hypotensive dose of enalapril  (0.1 mg/kg) could 
improve neurological activity (1.67±0.31) and failed to reduce cerebral infarction (276±39mm3) 
and swelling (10.4±1.4%). 
Conclusion: In the rat model of transient focal cerebral ischemia, inhibition of angiotensin 
converting  enzyme  with  non-hypotensive  doses  of  enalapril  has  the  benefit  of  improving 
neurological activity, reducing cerebral infarction, brain swelling and edema of acute ischemic 
stroke.  Therefore,  it  is  reasonable  to  conclude  that  central  renin-angiotensin  system  may 
participate in ischemic/reperfusion injury of the cerebral cortex. 
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INTRODUCTION
The critical role of renin–angiotensin system (RAS) 
in  cardiovascular  and  fluid  hemostasis  is  well 
established and some evidences exist about the role 
of  angiotensin-converting  enzyme  (ACE)  activity 
and angiotensin II in ischemic neuronal injury (1). 
It is suggested that inhibition of the RAS might be 
effective not only in reducing the incidence of stroke 
but also attenuating neuronal injury after stroke (2). 
Recent clinical studies revealed that ACE inhibitors, 
which are used as anti-hypertensive drugs, reduce 
the risk and the severity of secondary attacks of the 
stroke (3). Long term treatment with ACE inhibitors 
has shown to prevent the occurrence of stroke in 
spontaneously hypertensive or salt loaded-Dahl salt-
sensitive rats (4, 5). Moreover, ACE inhibitors are 
reported  to  improve  neurological  recovery  from 
cerebral ischemia/reperfusion (I/R) injury and reduce 
the  mortality  rate  in  spontaneously  hypertensive 
rats (6). Pathological remodeling of cerebral vessels 
that occur during chronic hypertension is reported 
to interfere with the outcome of ACE inhibition and 
other  neuroprotective  agents  (5).  Therefore,  this 
study  was  designed  to  induce  cerebral  I/R  injury 
in normotensive rats to alleviate the interaction of 
hypertension in protective action of ACE inhibitors. 
Experimental-induced transient focal cerebral ischemia 
is widely used to examine the functional impairments 
resemble to those that have been observed in human 
stroke (7). Previously the beneficial effects of non-
hypotensive  dose  of  enalapril,  an  ACE  inhibitor, 
in  improving  neurological  activity  and  reducing 
cerebral  infarction  volume  in  normotensive  rats 
exposed to 60 min middle cerebral artery occlusion 
(MCAO)  was  reported  (8).  Brain  edema  is  a 
destructive phenomenon that worsens cerebral I/R 
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brain ischemia achieved by 60 min MCAO followed 
by 24 h reperfusion.
Group  3  (enalapril  pre-treated  ischemic  rats  with 
0.03 mg/kg; n=14), rats received a single IP injection 
of 0.03 mg/kg of enalapril (Sigma Chemicals, UK) 
1  h  prior  to  MCAO. All  procedures  which  were 
performed on rats of group 2 were also repeated in 
this group. 
Group  4  (enalapril  pre-treated  ischemic  rats  with 
0.1 mg/kg; n=6), rats of this group received a single 
IP injection of 0.1 mg/kg of enalapril 1 h before 
induction of MCAO. Other procedures were similar 
to groups 2 and 3. Due to low survival rate the rats of 
this group that survived after 24 hrs reperfusion were 
only used for the evaluations of cerebral infarction 
volumes and brain swelling and were not used for 
the assessment of brain edema.
Induction of transient focal cerebral ischemia
Sixty min MCAO and 24 hrs reperfusion of the right 
cerebral  hemisphere  carried  out  by  intraluminal 
filament method described by Longa et al (10) and 
modified by Vakili et al (9). One hr after termination 
of ischemia all incisions which were made during 
surgery  sutured  and  after  recovery  the  animal 
returned to a warm cage for recuperation and housed 
during reperfusion period. Few rats of each group 
were randomly selected and their posterior tail artery 
cannulated  to  continuously  record  mean  arterial 
blood pressure (MAP) during the experiment. (Fig. 1) 
Behavioral  tests  were  performed  by  a  blinded 
observer 24 hrs after surgery in the sham group, or 24 
hrs after MCAO in the ischemic groups that survived 
the ischemic trauma. As described previously, five-
point scale grading neurological deficit score (NDS) 
test was carried out to evaluate the neurological 
outcome (8). After evaluation of NDS (Fig. 2) the rats 
of each group were randomly assigned to assess, 1) 
cerebral infarction volumes and 2) edema formations 
injury.  In  the  present  study  previous  experiments 
were  repeated  and  the  effects  of  enalapril  on  the 
intensity of tissue swelling and brain edema which 
was  induced  during  60  min  MCAO  and  24  hrs 
reperfusion was evaluated.
 
MATERIAL  AND  METHODS
Male normotensive Sprague Dawley rats (280-320 
g) were obtained from central animal house facility 
of  Shiraz  Medical  Sciences  University  (Shiraz, 
Iran). All protocols of the study were approved by 
the institutional animal ethics committee of Shiraz 
Medical Sciences University which follows the NIH 
guidelines  for care and use of animals. Animals were 
housed at room temperature of 22-24°C, humidity of 
40-60% and light period of 07.00-19.00 controlled 
environments.  The  animals  were  then  randomly 
divided into 4 groups.
Animals were food fasted overnight but had access 
to  water. Anesthesia  conducted  by  intraperitoneal 
(IP)  injection  of  400mg/kg  chloral  hydrate.  The 
trachea  was  cannulated  from  the  mouth  with  a 
polyethylene  tube  to  prevent  possible  asphyxia, 
artificially ventilate, or to oxygenate the animal in 
the case of hypoxia as described previously (8, 9). 
However, the animals were breathing spontaneously 
during surgery and the experiment. Core and cranial 
temperatures  were  recorded  continuously  by  two 
probes, one inserted into the rectum and the other 
in  the  vicinity  of  left  temporalis  muscle,  and  the 
temperature  maintained  at  37±1ºC  with  a  heating 
pad and a heating lamp.
Experimental protocol
Group 1 (sham, n=16), rats underwent the surgery 
at the neck region and received a single IP injection 
of the vehicle (1ml/kg normal saline) without being 
exposed to MCAO. 
Group 2 (control ischemic; n=15), rats received a 
single IP injection of the vehicle 1 h before MCAO. 
Afterwards, surgery performed at the neck region, 
the same as sham group. After resting for 30 min 
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Figure 1. Mean arterial blood pressure (MAP) in control ischemic 
(group 2; n=5) and ischemic rats pre-treated with enalapril at 
doses of 0.03 mg/kg (group 3; n=4) or 0.1 mg/kg (group 4; n=5) 
at 1 h before MCAO (pre-ischemia), 10 min after MCAO and 30 
min after MCA reopening (Reperfusion).
Values are mean ± SEM. 
* = values are significantly different from groups 2 and 3 at P<0.05,)
Figure 2. Neurological deficit score (NDS) in sham (group 1), 
control  ischemic  (group  2)  and  enalapril  pre-treated  rats  with 
0.03mg/kg (group 3) and 0.1mg/kg (group 4) subjected to 60 min 
MCA occlusion and 24 hrs reperfusion. Values are mean±SEM. 
* = Significantly different from group 1 (P<0.05). 
** = Significantly different from group 2 (p<0.05). 
$= Significantly different from groups 1 and 2 (p<0.05)
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Figure 4: Enalapril diminishes cerebral ischemia/reperfusion injury in normal rat 37
during I/R injury. Overall, approximately 35% of 
the animals of groups 2, 20% of group 3 and 54% of 
group 4 died during reperfusion period and their 
data could not be collected for the evaluations of 
NDS, cerebral infarction volumes or edema. 
After  NDS  the  animal  was  slaughtered  under  deep 
anesthesia,  the  brain  was  removed,  cleaned  and 
solidified by immersion in 4oC cold saline kept in the 
refrigerator for 5-10 min. Frontal sections of 2-mm 
thick slices were prepared using a brain matrix and 
stained  with  triphenyltetrazolium  chloride  (TTC) 
described previously (8, 9). In this staining technique, 
nonischemic  brain  region  was  colored  red  by 
converting TTC to a deep red formazan compound 
and ischemic areas remained white due to failure of 
conversion (Fig. 3). After staining, the slice images 
were digitized, using a Cannon camera, and cerebral 
infarction volume (Fig. 4) areas were determined with 
computer  based  NIH  image  analyzer  software  (8,  9). 
The tissue swelling induced in the lesioned hemispheres of 
TTC staining method was evaluated  (Fig. 5) using the 
equation 1 described by Swanson et al (11).
%Tissue swelling = [(LHV – NHV) / NHV]×100 (1) were
LHV  and  NHV are  Lesioned  and  Non-lesioned 
Hemisphere Volume.
The  more  accurate  way  of  determining  the  brain 
edema  formation  (Fig.  6,7)  during  I/R  injury  is 
to  use  wet/dry  method  described  by  Goth  and 
colleagues  (12).  The  percentage  of  brain  water 
content and edema formation for each hemisphere 
was  calculated  by  the  measurement  of  the  wet 
weight (WW) and dry weight (DW) of ipsilateral 
lesioned (LH) and contralateral non-lesioned (NH) 
hemispheres (Equations 2 and 3). 
Statistical analyses
Values  are  expressed  as  mean±SEM.  One-way 
ANOVA with post-hoc of Duncan’s test was used 
to compare the mean values of MAP. Holms-Sidack 
method  was  also  used  for  pairwise  comparisons 
of  other  parameters.  Statistical  significance  was 
accepted at P<0.05.
RESULTS AND  DISCUSSION
In this study the beneficial effects of enalapril, an 
ACE inhibitor on the neurological activity, cortical 
infarction  and  brain  edema  of  normotensive  rats 
exposed to 60 min middle cerebral artery occlusion 
were  investigated.  On  the  basis  of  reports,  the 
lowering arterial blood pressure reduces the risk of 
stroke in patients with the history of stroke, (13) or 
during  ischemia  in  experimental  animals  (14).  In 
chronic hypertensive rats reduction of MAP is an 
important  parameter  that  interferes  with  ischemic 
brain injury (15). On the basis of reports enalapril 
protect the brain from ischemic injury mainly by 
lowering arterial blood pressure (4, 14). To examine 
the protective actions of ACE inhibition in ischemic 
stroke without involvement of arterial hypotension 
the instruction of previous investigators about the 
dose of enalapril was followed and non-hypotensive 
dose  of  enalapril  (0.03  mg/kg)  was  chosen  for 
protection against acute stroke in normotensive rats 
(8, 15). The MAP of control ischemic rats of group 2 
WC (%) = [(WW - DW)/WW]×100                     (2)
Edema (%) = WCLH - WCNLH                                                       (3)
Figure  3.  Photographs  illustrating  the  coronal  sections  of  rat 
brain slices stained with TTC 24 hrs after neck surgery in sham 
(group 1) or after 60 min occlusion of middle cerebral artery and 
24 hrs reperfusion in control ischemic (group 2), and enalapril 
pre-treated  ischemic  rats  (0.03  or  0.1  mg/kg,  groups  3  and 
4)  as  described  in  the  text.  MCA  occlusion  induced  different 
magnitudes  of  infarctions  in  the  right  hemispheres  without 
affecting the left sides. Non-ischemic areas are colored deep red, 
whereas, ischemic areas are white. Note the similarity of ischemic 
areas of brain slices of groups 2 and 4. There is a marked decrease 
in the ischemic areas of group 3.
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Figure 4:  Figure 4. Cerebral infarct volume of ischemic (right) hemispheres 
in  control  (Group  2;  n=9),  and  enalapril  pre-treated  ischemic 
rats with 0.03mg/kg (Group 3; n=8) or 0.1mg/kg (group 4; n=5) 
subjected  to  60  min  MCA  occlusion  and  24  hrs  reperfusion. 
Animals received treatments 1 h before MCA occlusion. Values 
are mean ± SEM
* = significantly different from groups 2 and (P<0.05)Panahpour et al / DARU 2010 18 (1) 35-40 38
and 0.03 mg/kg enalapril pre-treated ischemic rats of 
group 3 during ischemia and reperfusion period were 
all in normal physiological range and quantitatively 
there were no statistical differences between them 
(Fig. 1). This similarity indicated that occlusion and 
re-opening of MCA as well as IP injection of 0.03 mg/
kg of enalapril (group 3) did not alter arterial blood 
pressure. However, results indicated that inhibition 
of ACE activity per se could improve neurological 
activity  (Fig.  2)  with  a  concomitant  reduction  of 
brain infarction (Fig. 3 and 4). This finding has the 
support of the pervious reports in that the protective 
effects of ACE inhibitors are independent of blood 
pressure reduction in chronic hypertensive rats (16).   
Some of these results are also in accordance with 
our previous report, in normotensive rats (8), and the 
reports of Ravati et al, in hypertensive rats (15). 
Asano et al, have indicated that ACE inhibitors reduce 
cerebrovascular  tone  and  potentiate  hyperperfusion 
phase of brain ischemia (17). Consequently cerebral 
vasodilatory action of ACE inhibitors help collateral 
vessels to have a better blood flow during ischemia 
and reperfusion phase to nourish the penumbra of 
ischemic region (4, 17). However in this study the 
persistence  of  severe  arterial  hypotension,  which 
is observed during ischemia and reperfusion phase 
of group 4, (Figure 1), might has reduced collateral 
circulations drastically and suppressed the protective 
actions of enalapril (Figures. 3 and 4). In agreement 
with  these  results,  previous  reports  showed  that 
acute reduction of arterial blood pressure after stroke 
worsens neurological outcome, whereas long-term 
blood pressure control may reduce the incidence of 
stroke and improves neurological activity (6, 14). 
This statement also has the support of other reports 
in that, in acute experimental ischemic stroke, the 
most likely mechanisms responsible for the benefits 
of reduced arterial blood pressure is the improvement 
of  blood  flow  during  reperfusion  period  and  the 
reduction of inflammatory damages that may occur 
afterward (14). 
Brain  edema  is  an  overriding  complication  of 
ischemic stroke that elevates intracranial pressure 
and degrades clinical outcomes (18). To examine the 
influence of ACE inhibition in brain edema formation 
two  independent  techniques  were  used,  and  the 
magnitude  of  edema  formation  during  I/R  injury 
were evaluated. The direct measurement of absolute 
WC of ipsilateral lesioned hemispheres in comparison 
with their own contralateral non-lesioned hemispheres, 
revealed that 60 min ischemia significantly elevated 
their WC. However, no differences were observed 
in the WC of non-lesioned hemispheres of all groups, 
in comparison to both hemispheres of sham-
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Figure 5. Percent tissue swelling of lesioned (right) hemispheres after 
60 min MCA occlusion and 24 hrs reperfusion in control ischemic 
(group 2) and enalapril pre-treated animals (0.03mg/kg; Group 3) or 
(0.1mg/kg; Group 4). 
* = significantly different from groups 2 and 4 at p<0.05).
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Figure 6. Brain water content (WC) of right and left hemispheres of 
sham 24 hrs after operation (group 1), and control ischemic (group 2) 
and 0.03 mg/kg enalapril pre-treated ischemic groups (group 3) after 
60 min occlusion of right MCA and 24 hrs reperfusion. 
Values are mean ± SEM
* = significantly different from ipsilateral hemispheres of groups 1 
and 2 (P<0.05) 
$ = Significantly different from ipsilateral hemispheres of group 1 
(p<0.05).
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Figure 7: 
Figure  7. Edema (%) of lesioned (right) hemispheres in control 
(group 2) and 0.03mg/kg enalapril pre-treated ischemic rats (group 
3) subjected to 60 min MCAO and 24 hrs reperfusion. 
Values are mean ± SEM
* = Significantly different from group 2 (P<0.05)
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operated rats, indicated that drug treatment and 
vascular  manipulation  of  lesioned  hemispheres 
did not affect their WC (Fig. 6). Therefore, the 
elevated WC of lesioned hemispheres showed that 
brain edema which occurred during I/R injury was 
prevented by 0.03 mg/kg enalapril (Fig. 7). These 
data quantitatively are comparable with the values 
reported by other reports (12, 19). The values of 
edema formation in ischemic hemispheres indicate 
that  the  trend  of  edema  formation  is  qualitatively 
well  correlated  with  the  tissue  swelling  (Fig. 7), 
and  the  magnitude  of  brain  swelling  is  also  well 
correlated with cerebral infarct size of ischemic 
rats. Therefore, in agreement with other reports 
(20), it is believed that inhibition of ACE during 
ischemia, which is not accompanied with severe 
hypotension, not only reduces cerebral infarction but 
it protects the lesioned brain from the side effects of 
edema formation.
CONCLUSION
The results of this study indicate that pre-treatment 
of normotensive rats with non-hypotensive dose of 
enalapril prevents the deterioration effects of ACE 
activity  in  cerebral  ischemia/reperfusion  injury. 
However,  high  dose  of  enalapril  associated  with 
severe arterial hypotension can not protect the brain 
from such injuries.
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